Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
izalontamab brengitecan (BL-B01D1)
i
Other names:
BL-B01D1, Iza-can
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
BMS, Biokin Pharma
Drug class:
EGFR-targeted antibody-drug conjugate, HER3-targeted antibody-drug conjugate
Related drugs:
‹
HTI-1511 (7)
DM001 (6)
MRG003 (6)
ABBV-321 (6)
LR004-VC-MMAE (5)
SHR-A1307 (4)
M1231 (3)
ABT-414 (3)
BB-1705 (2)
DM005 (2)
ABBV-221 (2)
AZD9592 (2)
ABBV-637 (0)
AVID100 (0)
CPO301 (0)
IMGN289 (0)
U3-1402 (28)
DB-1310 (4)
DM002 (4)
ORM-5029 (2)
AMT-562 (1)
HMBD-501 (1)
BNT326 (0)
SHR-A2009 (0)
HTI-1511 (7)
DM001 (6)
MRG003 (6)
ABBV-321 (6)
LR004-VC-MMAE (5)
SHR-A1307 (4)
M1231 (3)
ABT-414 (3)
BB-1705 (2)
DM005 (2)
ABBV-221 (2)
AZD9592 (2)
ABBV-637 (0)
AVID100 (0)
CPO301 (0)
IMGN289 (0)
U3-1402 (28)
DB-1310 (4)
DM002 (4)
ORM-5029 (2)
AMT-562 (1)
HMBD-501 (1)
BNT326 (0)
SHR-A2009 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR mutation
Non Small Cell Lung Cancer
EGFR mutation
Non Small Cell Lung Cancer
BL-B01D1
Sensitive: C2 – Inclusion Criteria
BL-B01D1
Sensitive
:
C2
BL-B01D1
Sensitive: C2 – Inclusion Criteria
BL-B01D1
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login